Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Randy M Schuller"'
Publikováno v:
PLoS Genetics, Vol 11, Iss 5, p e1005255 (2015)
Human neutrophil antigen 2 (HNA-2) deficiency is a common phenotype as 3-5% humans do not express HNA-2. HNA-2 is coded by CD177 gene that associates with human myeloproliferative disorders. HNA-2 deficient individuals are prone to produce HNA-2 allo
Externí odkaz:
https://doaj.org/article/586497cea169486f9bdfd0ba833ec8fe
Publikováno v:
Transfusion medicine (Oxford, England)REFERENCES.
We aimed to develop accurate and user-friendly genetic assays to identify the inherited neutrophil antigen-2 (HNA-2) deficiency in humans.HNA-2 is one of the most important neutrophil antigens implicated in a number of human disorders. HNA-2 deficien
Autor:
Behnaz Bayat, Randy M. Schuller, Anne Sophie Litmeyer, Yunfang Li, Jianming Wu, Ling Li, Gregor Bein, Ulrich J. Sachs
Publikováno v:
Transfusion. 59:1836-1842
Background Human neutrophil antigen-2 (HNA-2) is exclusively expressed on neutrophils. HNA-2-deficient individuals (HNA-2 null) are susceptible to produce isoantibodies. The nonsense CD177 coding single-nucleotide polymorphism (SNP) c.787A>T has been
Publikováno v:
Immunohematology. 26:11-21
Applying serologic procedures to the detection of RBC and lymphocyte antigens has facilitated the identification of granulocyte antigens with established clinical significance, which are now classified in the human neutrophil antigen system. Granuloc
Publikováno v:
PLoS Genetics, Vol 11, Iss 5, p e1005255 (2015)
PLoS Genetics
PLoS Genetics
Human neutrophil antigen 2 (HNA-2) deficiency is a common phenotype as 3–5% humans do not express HNA-2. HNA-2 is coded by CD177 gene that associates with human myeloproliferative disorders. HNA-2 deficient individuals are prone to produce HNA-2 al
Autor:
Brian R. Curtis, Samina Y. Khan, Patricia M. Kopko, Daniel R. Ambruso, Randy M. Schuller, Christopher C. Silliman, Marguerite R. Kelher, Baindu Sannoh
Publikováno v:
Blood. 109:1752-1755
Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-related mortality. Antibodies to HNA-3a are commonly implicated in TRALI. We hypothesized that HNA-3a antibodies prime neutrophils (PMNs) and cause PMN-mediated cytotox
Autor:
Lorraine Caruccio, Kelly Walkovich, David F. Stroncek, Randy M. Schuller, Maria P. Bettinotti
Publikováno v:
Transfusion. 44:77-82
BACKGROUND: Human neutrophil antigen-2a (NB1) is located on NB1 glycoprotein, which is expressed on subpopulations of neutrophils. PRV-1 is a gene that is over-expressed in neutrophils from patients with polycythemia rubra vera. The gene encoding NB1
Autor:
Rolf D. Hubmayr, Edward L. Murphy, Deanna C. Lee, Ognjen Gajic, Randy M. Schuller, Clifford A. Lowell, Barbara Grimes, Nora V. Hirschler, Michael A. Gropper, Peter Bacchetti, Pearl Toy, Monique Koenigsberg, Ping Wu, Mark R. Looney, Manish J. Gandhi, Rosa Sanchez Rosen, Michael A. Matthay, Jeffrey L. Winters, Gregory A. Wilson, David C. Mair, Nareg Roubinian, Philip J. Norris
Publikováno v:
Critical care medicine, vol 42, iss 7
ObjectiveTransfusion-related acute lung injury is the leading cause of transfusion-related mortality. A prospective study using electronic surveillance was conducted at two academic medical centers in the United States with the objective to define th
Autor:
Rolf D. Hubmayr, Edward L. Murphy, Manish J. Gandhi, Ognjen Gajic, Philip J. Norris, Gregory A. Wilson, David C. Mair, Michael A. Gropper, Ping Wu, Mark R. Looney, Monique Koenigsberg, Barbara Grimes, Peter Bacchetti, Richard B. Weiskopf, Rosa Sanchez Rosen, Pearl Toy, Michael A. Matthay, Nora V. Hirschler, Deanna C. Lee, Clifford A. Lowell, Jeffrey L. Winters, Randy M. Schuller
Publikováno v:
Toy, P; Gajic, O; Bacchetti, P; Looney, MR; Gropper, MA; Hubmayr, R; et al.(2012). Transfusion-related acute lung injury: Incidence and risk factors. Blood, 119(7), 1757-1767. doi: 10.1182/blood-2011-08-370932. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/0nf7j145
Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-related mortality. To determine TRALI incidence by prospective, active surveillance and to identify risk factors by a case-control study, 2 academic medical centers enr